Walgreens may be seeking shelter from a skeptical market for its stock in going private, but the massive debt it would likely take on in a private equity buyout could create its own set of problems if history is any indicator.
The drugstore retailer has had a bumpy year. Walgreens acknowledged its second quarter — in which retail comp sales fell 3.8% — was “disappointing.” It followed that up with another quarter of declining retail comps. For the full fiscal 2019 year, that figure is down 2.4%, as it was the year before, too.
